Hookipa Pharma News and Activities

Hookipa Pharma is a company listed under the stock ticker HOOK (AT).

View the org chart displaying its 16 main executives

Most searched biographies at Hookipa Pharma

• Malte Peters, Chief Executive Officer and Director
• David Kaufman, Director
• Sean Cassidy, Director

Create your alert
to follow the executive moves at Hookipa Pharma.

Hookipa Pharma has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Hookipa Pharma

• Press Releases | Hookipa Pharma Inc.
• Press Releases | Hookipa Pharma Inc.
• HOOKIPA Appoints Prof. Jean-Charles Soria, Director General of the Gustave Roussy Cancer Center in Paris, to its Board of Directors | Hookipa Pharma Inc.
• HOOKIPA Pharma to Present at SVB Leerink’s CybeRx Series Vaccine Forum | Hookipa Pharma Inc.
• HOOKIPA Pharma’s LCMV-based Immunotherapy for HPV16+ Cancers Demonstrates High Immunogenicity, According to Peer Reviewed Article | Hookipa Pharma Inc.
• HOOKIPA Pharma to Present at Upcoming Conferences in September | Hookipa Pharma Inc.
• HOOKIPA Pharma Reports Second Quarter 2020 Financial Results and Provides a Corporate Update | Hookipa Pharma Inc.
• HOOKIPA Pharma To Report Second Quarter 2020 Financial Results on August 13, 2020 | Hookipa Pharma Inc.
• HOOKIPA Announces Issuance of US and European Patents | Hookipa Pharma Inc.
• HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB‑101 | Hookipa Pharma Inc.
• View more press releases Close

Social media about Hookipa Pharma

• Hookipa Pharma on Wikipedia, Google News & Yahoo Finance
• Hookipa Pharma on LinkedIn, X (Twitter) & YouTube